Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Apr 12;10:757. doi: 10.3389/fimmu.2019.00757

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2019 Liubomirski, Lerrer, Meshel, Rubinstein-Achiasaf, Morein, Wiemann, Körner and Ben-Baruch.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

The expression levels of the pro-inflammatory cytokines TNFα and IL-1β and of their chemokine targets are significantly higher in basal patients than in luminal-A patients. The Figure demonstrates gene expression analyses, performed with the TCGA breast cancer dataset. (A) TNFα, (B) IL-1β, (C) CXCL8, (D) CCL2, (E) CCL5. (A1–E1) Boxplots comparing expression levels in basal patients and luminal-A patients. ***p < 0.001. (A2–E2) Histograms demonstrating the distribution of expression levels of each of the factors in basal and luminal-A patient tumors. RSEM, RNAseq by expectation-maximization.